Navigation Links
National Whistleblower Appreciation Day Declared to Ensure Recognition of Enormous Contribution to the Democracy by Whistleblowers, Parker Waichman LLP Comments
Date:7/31/2014

Port Washington, New York (PRWEB) July 31, 2014

Parker Waichman, LLP, a national law firm that represents whistleblowers in qui tam cases, comments that whistleblowers are a critical component of the process that puts an end to illegal employer activities that may cause harm to consumers and may defraud the government, and recognizes that today is National Whistleblower Appreciation Day.

According to a 2013 report issued by The National Whistleblower Center, the Senate declared "National Whistleblower Appreciation Day" on July 30, 2013; the resolution was reached by unanimous agreement on July 31, 2013. The Center indicated that it strongly supports the Senate action and urges all Americans to consider the enormous contribution that Whistleblowers have made to democracy in this country, as well as the long known struggles and sacrifices Whistleblowers have faced.

The resolution, known as S.Res.202, both designated "National Whistleblower Appreciation Day" and resolved that the Senate would ensure that the federal government implement what the Founding Founders had intended in their July 30, 1778 legislation; that the government’s executive agencies ensure that the public and employees and contractors who work on behalf of the country’s taxpayers, understand the legal rights of this country’s citizen to operate as whistleblowers; and that there is acknowledgment of the many contributions whistleblowers make to fight waste, fraud, abuse, and violations of the laws and regulations of the United States, The National Whistleblower Center explained.

In a statement celebrating last year’s passage of the "National Whistleblower Appreciation Day" Resolution, NWC Executive Director Stephen M. Kohn stated, in part, that, "In honor of ‘National Whistleblower Appreciation Day' we urge all Americans to reflect on these past sacrifices and accomplishments and show support for the whistleblowers today who are fighting to defend their reputations, their jobs, and their freedom after exposing lies at the highest levels of government and frauds that have robbed tax-payers and investors of countless billions. The Senate's establishment of ‘National Whistleblower Appreciation Day' is a historic first step in changing the hostile workplace culture that had made it so difficult on American's to fulfill the ‘duty,' recognized by our Founding Fathers, to blow the whistle in the public interest."

The False Claims Act provides whistleblowers with protection and the ability to be compensated for their work. Passed in 1863 during the Civil War, the Act includes a number of amendments added in 1986 that increased damage and penalty amounts meant to help induce whistleblowers to come forward. With whistleblower awards ranging 15-30 percent of damage and penalty amounts, whistleblowers may receive awards in the millions of dollars, notes Parker Waichman LLP.

The Dodd-Frank Whistleblower Law also enables whistleblowers who report a securities fraud complaint to remain anonymous when working through a whistleblower attorney. In fact, not only is a whistleblower attorney necessary for whistleblower confidentiality, your attorney may help to increase the award size. Also under the Dodd-Frank Whistleblower Law, anonymity is maintained until a cash award is paid. Once the award is paid, the whistleblower name must be released. Should the Securities Exchange Commission (SEC) opt against pursuing a securities fraud action, the whistleblower name will never be released.

Whistleblowers have been crucial in assisting the federal government in recovering billions of dollars illegally obtained by drug and device makers, consumer product manufacturers, and other businesses, and have also helped in saving the lives of untold numbers of consumers who were unaware of the side effects of their medical devices, the medications they were prescribed, and the products to which they were exposed. Whistleblower lawyers have been equally important in maintaining whistleblower anonymity in these cases.

“When companies exert abuses of power or take part in illegal or unethical financial activities, they not only defraud the government, they are defrauding unsuspecting tax payers,” said Gary Falkowitz, Managing Attorney at Parker Waichman LLP. “Parker Waichman LLP has long supported whistleblower efforts to report illegal activities that may harm citizens and defraud government programs and firmly believes that whistleblowers play a necessary role in holding these parties responsible.”

Parker Waichman LLP supports efforts to protect whistleblowers and offers free legal evaluations to those individuals who believe their companies may be involved in wrongdoings. If you believe that a consumer product manufacturer, a medical device maker, or a pharmaceutical company is committing fraudulent activities and would like to maintain your anonymity, we encourage you to contact us at the firm’s Whistleblower page at yourlawyer.com or call 1-800-LAW-INFO (1-800-529-4636).

Read the full story at http://www.prweb.com/releases/2014/08/prweb12064086.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. MU receives national award for using mind-body approach to improve health
2. International breast health global summit will focus on supportive care and quality of life
3. International conference to explore health of descendants of transatlantic slave trade
4. National poll: Low cost, lifesaving services missing from most older patients health care
5. UT MD Anderson President Ronald DePinho elected to National Academy of Sciences
6. Kessler Foundation researchers present at first International Congress on Cognition in MS
7. Dr. Yael Mosse will receive first Nachman Award in Pediatric Oncology at national conference
8. Georgetown physician leads national resveratrol study for Alzheimers disease
9. National initiative launched to change the way biology departments approach undergraduate education
10. Boston researcher, surgical oncologist receives national award
11. Internationally known expert in ovarian cancer to be honored at the ASCO Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media ... Pro X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice ... X users can now reveal the media of their split screens with growing ...
(Date:6/26/2016)... (PRWEB) , ... June 27, 2016 , ... Quality metrics ... yet in many ways they remain in the eye of the beholder, according to ... a publication of The American Journal of Managed Care. For the full issue, ...
(Date:6/26/2016)... , ... June 26, 2016 , ... ... once they have been diagnosed with endometriosis. These women need a treatment plan ... require a comprehensive approach that can help for preservation of fertility and ultimately ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... First ... United States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell ... facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: